open/close global search bar

22 July 2018 by Sanjiv Shah

Conference talk

Neladenoson bialanate in patients with chronic HFpEF (PANACHE)

About the author

profile picture of Sanjiv Shah

Sanjiv Shah

United States

Comments (0)

Related Content

John Scandurra & Irene Lang - Implantable devices to improve pulmonary circulation compliance thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("John Scandurra & Irene Lang - Implantable devices to improve pulmonary circulation compliance", 65)}}
Kelly Chin - Efficacy and safety of initial triple oral versus initial double oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: Results of the randomised controlled TRITON study (NCT02558231) thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Kelly Chin - Efficacy and safety of initial triple oral versus initial double oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: Results of the randomised controlled TRITON study (NCT02558231)", 65)}}
Shao-Liang Chen -PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335) thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Shao-Liang Chen -PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335)", 65)}}
Ronald Oudiz - ABI-009, an mToR Inhibitor, for patients with severe pulmonary arterial hypertension (NCT02587325) thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Ronald Oudiz - ABI-009, an mToR Inhibitor, for patients with severe pulmonary arterial hypertension (NCT02587325)", 65)}}
Erika Rosenzweig - A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Erika Rosenzweig - A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg